242 related articles for article (PubMed ID: 32786121)
21. SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer.
Wei M; Huang X; Liao L; Tian Y; Zheng X
Cancer Res; 2023 Sep; 83(17):2908-2923. PubMed ID: 37350666
[TBL] [Abstract][Full Text] [Related]
22. MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.
Lemma RB; Ledsaak M; Fuglerud BM; Rodríguez-Castañeda F; Eskeland R; Gabrielsen OS
J Biol Chem; 2023 Sep; 299(9):105062. PubMed ID: 37468105
[TBL] [Abstract][Full Text] [Related]
23. The SUMO protease SENP1 and the chromatin remodeler CHD3 interact and jointly affect chromatin accessibility and gene expression.
Rodríguez-Castañeda F; Lemma RB; Cuervo I; Bengtsen M; Moen LM; Ledsaak M; Eskeland R; Gabrielsen OS
J Biol Chem; 2018 Oct; 293(40):15439-15454. PubMed ID: 30082317
[TBL] [Abstract][Full Text] [Related]
24. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
25. SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.
Fasci D; Anania VG; Lill JR; Salvesen GS
Sci Signal; 2015 Jun; 8(380):ra56. PubMed ID: 26060329
[TBL] [Abstract][Full Text] [Related]
26. SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.
Li X; Luo Y; Yu L; Lin Y; Luo D; Zhang H; He Y; Kim YO; Kim Y; Tang S; Min W
Cell Death Differ; 2008 Apr; 15(4):739-50. PubMed ID: 18219322
[TBL] [Abstract][Full Text] [Related]
27. The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation.
Nishida T; Yamada Y
Biochem Biophys Res Commun; 2011 Mar; 406(2):285-91. PubMed ID: 21316347
[TBL] [Abstract][Full Text] [Related]
28. Exploring the desumoylation process of SENP1: a study combined MD simulations with QM/MM calculations on SENP1-SUMO1-RanGAP1.
Shi T; Han Y; Li W; Zhao Y; Liu Y; Huang Z; Lu S; Zhang J
J Chem Inf Model; 2013 Sep; 53(9):2360-8. PubMed ID: 23930863
[TBL] [Abstract][Full Text] [Related]
29. SUMO-specific protease 2 in Mdm2-mediated regulation of p53.
Jiang M; Chiu SY; Hsu W
Cell Death Differ; 2011 Jun; 18(6):1005-15. PubMed ID: 21183956
[TBL] [Abstract][Full Text] [Related]
30. SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis.
Yu L; Ji W; Zhang H; Renda MJ; He Y; Lin S; Cheng EC; Chen H; Krause DS; Min W
J Exp Med; 2010 Jun; 207(6):1183-95. PubMed ID: 20457756
[TBL] [Abstract][Full Text] [Related]
31. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets.
Hajmrle C; Ferdaoussi M; Plummer G; Spigelman AF; Lai K; Manning Fox JE; MacDonald PE
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E664-73. PubMed ID: 25139051
[TBL] [Abstract][Full Text] [Related]
32. Sentrin/SUMO specific proteases as novel tissue-selective modulators of vitamin D receptor-mediated signaling.
Lee WP; Jena S; Doherty D; Ventakesh J; Schimdt J; Furmick J; Widener T; Lemau J; Jurutka PW; Thompson PD
PLoS One; 2014; 9(2):e89506. PubMed ID: 24586832
[TBL] [Abstract][Full Text] [Related]
33. SUMOylation regulates insulin exocytosis downstream of secretory granule docking in rodents and humans.
Dai XQ; Plummer G; Casimir M; Kang Y; Hajmrle C; Gaisano HY; Manning Fox JE; MacDonald PE
Diabetes; 2011 Mar; 60(3):838-47. PubMed ID: 21266332
[TBL] [Abstract][Full Text] [Related]
34. Regulation of post-translational modification in breast cancer treatment.
Heo KS
BMB Rep; 2019 Feb; 52(2):113-118. PubMed ID: 30638182
[TBL] [Abstract][Full Text] [Related]
35. Identification of proximal SUMO-dependent interactors using SUMO-ID.
Barroso-Gomila O; Trulsson F; Muratore V; Canosa I; Merino-Cacho L; Cortazar AR; Pérez C; Azkargorta M; Iloro I; Carracedo A; Aransay AM; Elortza F; Mayor U; Vertegaal ACO; Barrio R; Sutherland JD
Nat Commun; 2021 Nov; 12(1):6671. PubMed ID: 34795231
[TBL] [Abstract][Full Text] [Related]
36. Progress in the Discovery of Small Molecule Modulators of DeSUMOylation.
Chen S; Dong D; Xin W; Zhou H
Curr Issues Mol Biol; 2020; 35():17-34. PubMed ID: 31422931
[TBL] [Abstract][Full Text] [Related]
37. Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53.
Lin JY; Ohshima T; Shimotohno K
FEBS Lett; 2004 Aug; 573(1-3):15-8. PubMed ID: 15327968
[TBL] [Abstract][Full Text] [Related]
38. The IL-6 family of cytokines modulates STAT3 activation by desumoylation of PML through SENP1 induction.
Ohbayashi N; Kawakami S; Muromoto R; Togi S; Ikeda O; Kamitani S; Sekine Y; Honjoh T; Matsuda T
Biochem Biophys Res Commun; 2008 Jul; 371(4):823-8. PubMed ID: 18474224
[TBL] [Abstract][Full Text] [Related]
39. SUMO protease SENP1 induces isomerization of the scissile peptide bond.
Shen L; Tatham MH; Dong C; Zagórska A; Naismith JH; Hay RT
Nat Struct Mol Biol; 2006 Dec; 13(12):1069-77. PubMed ID: 17099698
[TBL] [Abstract][Full Text] [Related]
40. SUMOylation of the ubiquitin ligase IDOL decreases LDL receptor levels and is reversed by SENP1.
Wang JQ; Lin ZC; Li LL; Zhang SF; Li WH; Liu W; Song BL; Luo J
J Biol Chem; 2021; 296():100032. PubMed ID: 33154164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
